- Home
- INTJ vs ABVC Comparison
INTJ vs ABVC Comparison
Compare INTJ & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTJ
- ABVC
- Stock Information
- Founded
- INTJ 2016
- ABVC 2015
- Country
- INTJ Hong Kong
- ABVC United States
- Employees
- INTJ N/A
- ABVC N/A
- Industry
- INTJ
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- INTJ
- ABVC Health Care
- Exchange
- INTJ NYSE
- ABVC Nasdaq
- Market Cap
- INTJ 12.7M
- ABVC 12.8M
- IPO Year
- INTJ 2024
- ABVC N/A
- Fundamental
- Price
- INTJ $0.81
- ABVC $0.54
- Analyst Decision
- INTJ
- ABVC
- Analyst Count
- INTJ 0
- ABVC 0
- Target Price
- INTJ N/A
- ABVC N/A
- AVG Volume (30 Days)
- INTJ 244.5K
- ABVC 150.8K
- Earning Date
- INTJ 11-01-2024
- ABVC 03-12-2025
- Dividend Yield
- INTJ N/A
- ABVC N/A
- EPS Growth
- INTJ 30.19
- ABVC N/A
- EPS
- INTJ 0.07
- ABVC N/A
- Revenue
- INTJ $2,341,977.00
- ABVC $509,788.00
- Revenue This Year
- INTJ N/A
- ABVC N/A
- Revenue Next Year
- INTJ N/A
- ABVC N/A
- P/E Ratio
- INTJ $11.66
- ABVC N/A
- Revenue Growth
- INTJ 25.78
- ABVC N/A
- 52 Week Low
- INTJ $0.75
- ABVC $0.41
- 52 Week High
- INTJ $7.87
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- INTJ N/A
- ABVC 47.67
- Support Level
- INTJ N/A
- ABVC $0.50
- Resistance Level
- INTJ N/A
- ABVC $0.58
- Average True Range (ATR)
- INTJ 0.00
- ABVC 0.06
- MACD
- INTJ 0.00
- ABVC -0.01
- Stochastic Oscillator
- INTJ 0.00
- ABVC 20.63
About INTJ INTELLIGENT GROUP LTD
Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through IJL, its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.